about
Surgery for atrial fibrillationCalcium dysregulation in atrial fibrillation: the role of CaMKII2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Evaluating the benefits of home-based management of atrial fibrillation: current perspectivesEffect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trialsAntiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.Alternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more.Patient outcomes according to adherence to treatment guidelines for rhythm control of atrial fibrillationA general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmicsThe Use of Gene Therapy for Ablation of Atrial Fibrillation.Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillationAvoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?Atrial fibrillation: mechanisms, therapeutics, and future directions.Management of Patients with Atrial Fibrillation: Focus on Treatment Options.New directions in antiarrhythmic drug therapy for atrial fibrillation.Surgical techniques used for the treatment of atrial fibrillationHomogenization of Atrial Electrical Activities: Conceptual Restoration of Regional Electrophysiological Parameters to Deter Ischemia-Dependent Conflictogenic Atrial Fibrillation.Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation.Antiarrhythmic therapy as an adjuvant to promote post pulmonary vein isolation success-a meta-analysis.Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur InhibitorSynergistic Effect of Dofetilide and Mexiletine on Prevention of Atrial Fibrillation.Dronedarone-digoxin interaction in PALLAS: A foxglove connection?Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.Have the Findings from Clinical Risk Prediction and Trials Any Key Messages for Safety Pharmacology?Pleiotropic actions of amiodarone: still puzzling after half a century.Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses.A meta-analysis on Omega-3 supplements in preventing recurrence of atrial fibrillation.Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.Management of Arrhythmias in Heart Failure.Inhibition of BKCa negatively alters cardiovascular function.Atrial fibrillationEfficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation
P2860
Q27022070-CD0F78E3-54A5-4C99-81FB-B1659B497A51Q27027326-F47468C9-4952-4804-A15B-45BDA4FFEC11Q27341873-B26750C1-5A03-4138-9C54-8712CEF9BA5BQ28079137-B80D28A0-86E0-4897-8D9B-F8BD4986F0D6Q28087109-7430E936-59C3-4EA2-A974-B59E51C4CE15Q34973496-D461AAE7-1FE4-4AFE-8788-AD41BA86DC04Q35062038-91C23836-1D74-402A-944A-FB620CFA77FCQ36085708-C5C4B007-B287-4D90-B173-0265CA7C8647Q36333201-78A74144-B063-4E63-9206-CD2A4C4B3DBDQ36458906-C6FCDD77-3C52-4756-B06F-4779E9FD783FQ36514742-54477875-2A72-4597-B4FF-7988D360B67EQ36709675-15A744E7-071E-49C2-8B89-D831FF7AA135Q37106753-364A2DBC-A831-48CB-83DC-3565CA4372C6Q37412467-2BAD9333-6C5B-4A46-99A9-8495ADAFB198Q37495932-12867105-5107-4861-80E8-525E14ED0F3EQ37496339-B9DCE798-CD61-4771-BFCD-4C62972A4F6CQ37590158-A6410A8A-299C-4671-8895-A0AC5568C670Q37723881-3AEC574B-D8EC-4122-BCFD-A56A5F8A02AEQ38069201-D671A209-E16A-444D-BDBE-F4E250552AE3Q38119110-78BA7948-9D7F-4B71-AA1D-BA75E8368220Q38790375-83A2A18B-7FE0-4F40-A26C-D9D71E47D03AQ38853630-D292E6DD-9E2A-46A5-8E37-7EF62BD16396Q38880992-2D5A5C64-6B67-463B-AE09-C122F31B8768Q41064039-56D6326A-FC2C-47F5-BB01-1201A0354CEEQ41104424-4C9D3A7D-B70B-4466-8754-402122DD44F0Q41129947-740214C7-8DA9-4BD7-8D49-73A85813CD7FQ44360762-127EBF8E-BE7A-4215-B3B8-FDA6D4859696Q46502909-EA70428E-17CB-45E8-AD2E-6B92FEEA3359Q46607609-38C3CE8E-7885-40A7-901A-C469B857B005Q46907800-D03E6910-5A45-4928-87E4-D839A9D27630Q49183821-2DFA9F44-FADF-4193-85D1-58CBEEFDE788Q50042964-40EBE7ED-D190-4E4D-B1FD-F9E9C9112961Q55090406-26368010-0F1A-4208-91CC-9F72F5206F1BQ55315730-E65F4CA9-7B56-4575-BBF6-4BBA4BCF9B61Q55356627-C3C841F8-7C1E-42A7-BA19-1876171E655CQ56607936-DDB3D61F-898D-43DF-BB9F-7DB9D83C5C7CQ58799919-49654D0E-34D2-4ACE-8933-C38FFF3CE9EC
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antiarrhythmic drug therapy for atrial fibrillation
@ast
Antiarrhythmic drug therapy for atrial fibrillation
@en
Antiarrhythmic drug therapy for atrial fibrillation
@nl
type
label
Antiarrhythmic drug therapy for atrial fibrillation
@ast
Antiarrhythmic drug therapy for atrial fibrillation
@en
Antiarrhythmic drug therapy for atrial fibrillation
@nl
prefLabel
Antiarrhythmic drug therapy for atrial fibrillation
@ast
Antiarrhythmic drug therapy for atrial fibrillation
@en
Antiarrhythmic drug therapy for atrial fibrillation
@nl
P3181
P1433
P1476
Antiarrhythmic drug therapy for atrial fibrillation
@en
P2093
P. Zimetbaum
P3181
P356
10.1161/CIRCULATIONAHA.111.019927
P407
P577
2012-01-17T00:00:00Z